Patient assistance sits at the center of this dementia and brain health question.
Patient assistance programs, or PAPs, are manufacturer-run programs that provide free or nearly free prescription medications to Americans who cannot afford them. If you are uninsured, underinsured, or living on a limited income, you may qualify to receive your medications at no cost directly from the drug company that makes them. Since 2005, PhRMA’s Partnership for Prescription Assistance alone has helped an estimated 5.5 million Americans obtain their medications through these programs, and dozens of major pharmaceutical companies operate their own versions today. The need has never been more urgent.
According to GoodRx research, 38 percent of Americans worried about affording their medications in 2025, a sharp increase from 27 percent just a year earlier. One in five people who filled a prescription in 2025 reported rationing their medications due to cost, meaning they skipped doses, split pills, or delayed refills to stretch their supply. For people managing chronic conditions tied to brain health and cognitive decline, that kind of rationing can have serious consequences. This article walks through exactly how these programs work, who qualifies, how to apply, and what limitations you should know about before counting on them.
Table of Contents
- What Are Patient Assistance Programs and Who Gets Free Medications?
- How the Major Drug Companies Structure Their Programs
- The Application Process and What You Will Need
- Where to Search for the Right Program
- Limitations That Could Affect Your Coverage
- The Coming Coverage Gap and Why PAPs May Matter More in 2026
- What May Change Going Forward
- Conclusion
- Frequently Asked Questions
What Are Patient Assistance Programs and Who Gets Free Medications?
Patient assistance programs are not government benefits. They are programs funded and administered by pharmaceutical manufacturers themselves. Each major drug company runs its own PAP with its own application, eligibility criteria, and list of covered medications. The basic idea is straightforward: if you cannot afford a medication and you meet certain income and insurance requirements, the company that makes your drug may give it to you for free. This is not a discount card or a coupon. These programs provide the actual medication at no charge, typically shipped to your doctor’s office or a specialty pharmacy. Most PAPs set their income cutoffs somewhere between 200 and 400 percent of the Federal Poverty Level. For 2026, the federal poverty level is $15,960 per year for a single person and $33,000 for a family of four.
At 300 percent of FPL, which is a common threshold, a single person earning up to roughly $47,880 per year or a family of four earning up to approximately $99,000 per year could qualify. That range is broader than many people expect. You do not have to be destitute to be eligible. A retired couple living on Social Security and a modest pension, for example, may well fall within the qualifying range for several manufacturer programs. The catch is that eligibility is not universal. Each company sets its own rules about insurance status, and those rules vary significantly. Some programs are open to Medicare Part D enrollees. Others exclude anyone with commercial insurance. You have to check each program individually, and if you take medications from three different manufacturers, you may need to submit three separate applications.
How the Major Drug Companies Structure Their Programs
The largest pharmaceutical companies each run distinct programs with different income thresholds and insurance restrictions. Pfizer RxPathways, one of the most widely used PAPs, sets its income cutoff at 300 percent of the federal poverty level. However, it is only available to patients who are uninsured or enrolled in government insurance like Medicare Part D, Medicaid, TRICARE, or VA benefits. If you have commercial insurance through an employer, you are not eligible for Pfizer’s program regardless of your income. Eli Lilly takes a different approach with Lilly Cares. The program provides qualifying Lilly medications at no cost, but it excludes patients enrolled in Medicaid, those receiving the full Low-Income Subsidy for Medicare, and veterans receiving VA benefits.
If you need a Lilly medication and fall into one of those categories, you would need to explore other options. Merck Helps provides free medicines and vaccines specifically to people without prescription drug or health insurance who cannot afford their Merck medications, though hardship exceptions are available on a case-by-case basis. Novo Nordisk sets its threshold as low as 200 percent of FPL for Ozempic but extends eligibility up to 400 percent of FPL for other medications. The takeaway here is that there is no single “patient assistance program.” There are hundreds of them, each with its own rules. A person who qualifies for one company’s program may be flatly rejected by another, even at the same income level. This is why checking each manufacturer’s program individually matters so much, and why broad statements about PAP eligibility can be misleading.
The Application Process and What You Will Need
Applying for a patient assistance program is not as simple as filling out an online form. Most programs require proof of income, details about your prescription, documentation of your insurance status, and a signature from your prescribing physician. Your doctor’s involvement is not optional. These programs are designed so that medications flow through a healthcare provider, not directly to patients browsing a website. Applications can typically be submitted by mail, fax, or email, and some programs now offer online submission. But the process can take several weeks.
If you are running out of a medication today, a PAP application is not an immediate solution. Some programs offer bridge supplies or emergency provisions while your application is under review, but not all do. Planning ahead matters. If you know your insurance situation is about to change, or if you are approaching retirement and will lose employer coverage, starting the application process early can prevent a gap in your medication supply. For someone managing a condition like Alzheimer’s disease or another form of dementia, the application process can be especially challenging. The person who needs the medication may not be in a position to navigate paperwork, gather income documents, or coordinate with a doctor’s office. Caregivers and family members often end up handling these applications, and it helps to know going in that you will need tax returns or pay stubs, a current prescription, and time set aside to work with the prescribing physician’s office.
Where to Search for the Right Program
Because each manufacturer runs its own PAP, finding the right program for a specific medication requires some research. Several free databases exist to help. NeedyMeds, available at needymeds.org, lets you search by drug name, diagnosis, or program and is one of the most comprehensive resources available. RxAssist at rxassist.org maintains a detailed directory of patient assistance programs. The Partnership for Prescription Assistance at helpingpatients.org offers another searchable tool. For Medicare beneficiaries specifically, CMS maintains a list of manufacturer PAPs on Medicare.gov. The tradeoff between these resources is worth understanding.
NeedyMeds tends to have the broadest database and includes not just manufacturer programs but also state programs, discount cards, and copay assistance foundations. RxAssist is often more curated and easier to navigate but may not include every smaller program. Neither database is perfect, and neither is updated in real time. A program’s eligibility criteria or availability can change without the database reflecting it immediately. If you find a program that looks like a match, go directly to the manufacturer’s website or call their dedicated phone line to confirm current details. For Lilly medications, the direct number is 1-855-559-8783. For Merck, it is 1-800-727-5400. These phone lines can confirm eligibility, walk you through the application, and sometimes flag alternative programs you might not have found on your own.
Limitations That Could Affect Your Coverage
Patient assistance programs have real limitations that do not always get discussed. The most significant one for older Americans involves Medicare. Federal regulations generally prohibit manufacturers from providing direct PAP support to patients enrolled in federally funded insurance programs, with limited exceptions. This means that if you are on Medicare Part D, some manufacturer programs will not accept your application at all. Others have carved out narrow exceptions, but the rules are complex and change frequently. Transparency is another concern.
Research published through the National Institutes of Health found that only about 4 percent of PAPs disclose how many patients they have actually helped, and more than half do not publicly disclose their income eligibility criteria. That means you may spend time gathering documents and completing an application without a clear sense of whether you are likely to be approved. There is no centralized appeals process if you are denied, and manufacturers are under no legal obligation to accept every qualifying applicant. There is also the question of continuity. PAP approvals are typically granted for a set period, often six months to a year, after which you must reapply. If your income changes, if the program’s criteria shift, or if the manufacturer discontinues the program, you could lose access to a medication you have come to depend on. For someone managing a progressive condition like dementia, where medication consistency matters, this uncertainty is a real concern that families should plan around.
The Coming Coverage Gap and Why PAPs May Matter More in 2026
The relevance of patient assistance programs is likely to grow in the near term. According to NPR reporting, an estimated 4.8 million Americans may lose health coverage in 2026 as enhanced Affordable Care Act subsidies expire. KFF research indicates that roughly 15 percent of Americans already have no or marginal prescription drug coverage.
Those two trends together mean a significant number of people could find themselves unable to afford medications they are currently taking. For families already managing the costs of dementia care, which often includes not just medications but also home health aides, adult day programs, and eventual facility care, losing prescription drug coverage could force impossible choices. Patient assistance programs will not solve the broader coverage gap, but for specific high-cost medications, they may be the difference between continuing treatment and going without.
What May Change Going Forward
The landscape of prescription drug affordability is shifting. The Inflation Reduction Act has begun capping out-of-pocket costs for some Medicare beneficiaries, and additional drug price negotiations are expected to affect more medications in the coming years. These policy changes could reduce the number of people who need PAPs for certain drugs, but they will not eliminate the need entirely.
Manufacturer programs will likely remain essential for uninsured Americans and for medications not yet subject to price negotiations. What would help most is greater transparency. If manufacturers disclosed their acceptance rates, processing times, and eligibility criteria in standardized formats, patients and caregivers could make informed decisions instead of applying blindly and hoping for the best. Until that changes, the burden falls on families to do the research, ask the right questions, and apply early enough to avoid gaps in treatment.
Conclusion
Patient assistance programs are a genuinely valuable resource that too few Americans know about. They provide free medications to millions of people who might otherwise go without, and the income thresholds are often higher than people assume. For families managing dementia or other chronic conditions, these programs can meaningfully reduce the financial burden of long-term care. But they are not a safety net in the traditional sense.
Each program has its own rules, its own application, and its own limitations. Medicare restrictions, lack of transparency, and the need to reapply regularly all create friction. The best approach is to start early, use resources like NeedyMeds and RxAssist to identify relevant programs, involve your doctor’s office from the beginning, and have a backup plan in case an application is denied or a program changes its terms. These programs exist and they work, but they require effort to access and vigilance to maintain.
Frequently Asked Questions
Can I get free dementia medications through a patient assistance program?
It depends on the manufacturer. If your dementia medication is made by a company that operates a PAP, and you meet their income and insurance requirements, you may be eligible to receive it at no cost. Check NeedyMeds or RxAssist to search by drug name.
Do I qualify for a patient assistance program if I have Medicare?
Some programs accept Medicare Part D enrollees, but many do not due to federal regulations that restrict manufacturer support for patients in federally funded insurance programs. You will need to check each manufacturer’s specific rules.
How long does it take to get approved for a PAP?
Processing times vary by manufacturer but typically range from a few weeks to over a month. Some programs offer bridge supplies of medication while your application is under review. Apply well before you run out of your current supply.
Can a family member or caregiver apply on behalf of a patient?
Yes. Most programs allow a caregiver or authorized representative to complete the application, which is especially important for patients with cognitive impairment who may not be able to manage the paperwork themselves.
What happens if my income is slightly above the cutoff?
Some programs, like Merck Helps, offer hardship exceptions on a case-by-case basis. It is worth applying and explaining your circumstances even if your income is near the threshold, as medical expenses and caregiving costs may be taken into account.
Do I have to reapply every year?
Most PAPs require reapplication every six months to one year. You will need to submit updated income documentation and maintain an active prescription from your doctor each time you reapply.
You Might Also Like
- Why Some Human Drugs Work in Pets — But Others Are Deadly
- The Hepatitis B Drug That Controls the Virus but Never Cures It
- The Autoimmune Biologic That Works by Depleting One Specific Cell Type
For more, see Alzheimer’s Association.
